A real successful campaign where the day-of media pitch push (synchronized with a BioBuzz feature) produced multiple Tier-1 pickups within 48 hours. All client-identifying details have been replaced with placeholders for illustration.
About this template
This file shows how a coordinated day-of media pitch push works for a multi-region announcement. The same announcement (a CEO transition at a life sciences professional services firm with offices in three regions) was pitched to local business press in each region simultaneously, anchored by a BioBuzz exclusive feature.
The dashboard's "📞 Day-of media pitch push" step is exactly this practice. This template gives Alain a tangible reference for what that activity looks like end-to-end.
The pattern
Tier 1 contacts get embargo-access 24–48 hours ahead of the wire
BioBuzz publishes the exclusive industry feature at a set time
Pitches go out simultaneously to Tier 1 + Tier 2 regional contacts (this is the "day-of push")
Each region gets its own angle — the same news, framed for that region's readership
Amplification network is notified after earned coverage runs
Pitch 1 — Region A
Pitch 2 — Region B
Pitch 3 — Region C (HQ)
Execution Checklist
Region A — Mid-Atlantic City / State
Local angle for hometown executive named to global CEO role.
Tier 1
Regional Business Magazine
Subject[City] Biotech Executive Named CEO of Global Life Sciences Firm — [State] Story
📬 Recipients (5 contacts)
Name
Title
Outlet
Email
Richard Foster
Reporter
Regional Business Magazine
editor1@regional-business.com
Kate Andrews
Reporter
Regional Business Magazine
editor2@regional-business.com
Katherine Schulte
Deputy Editor
Regional Business Magazine
depeditor@regional-business.com
Sarah Chen
Business Editor
Regional Business Magazine
sarah.chen@regional-business.com
Marcus Lee
Industry Reporter
Regional Business Magazine
mlee@regional-business.com
Hi [First Name],
A [City] life sciences executive just stepped into the CEO seat of a global firm — and I think it's a [Regional Business] story.
WHY YOUR READERS WILL CARE
A [City] executive with 200+ patents is named CEO of a global life sciences firm — a homegrown success story for [Regional Business] readers.
[Company] serves pharmaceutical, biotech, and medical device clients across the full product lifecycle — a core growth sector for the [State].
The story lands as [State]'s pharma corridor accelerates: [recent regional pharma investment] and a [recent workforce/training initiative] signal the region's rising stature in life sciences.
A planned, founder-to-successor transition built on 22 years of institutional knowledge — a model for [State]'s growing life sciences executive class.
[New CEO Name], a [City]-based biotech executive with more than 200 patents and 20+ years in the life sciences industry, has been named Chief Executive Officer of [Company], a global life sciences professional services firm. [New CEO] previously co-founded [Prior Company], where they helped build and commercialize breakthrough therapies. They step up from President and Chief Innovation Officer, where they have led [Company]'s operations and growth strategy since [date] — the promotion formalizes leadership they have already been exercising.
The [State] angle:[New CEO] is deeply rooted in the [City] life sciences ecosystem — a community that is emerging as a significant node in [State]'s pharmaceutical and biotech corridor.
BioBuzz — the leading life sciences industry media platform — is publishing an exclusive feature on this announcement today. I'm bringing you the [State] story that complements that national industry coverage: a [City] executive taking the helm of a global firm at a pivotal moment for the [State]'s life sciences sector.
For additional background, interviews, or a copy of the full press release, please contact [Comms Contact Name], [Title] at [Company]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Tier 2
Local Daily / Weekly / Community News
Subject[City]'s [New CEO Name] Named CEO of Global Biotech Firm
📬 Recipients (8 contacts across 3 outlets)
Name
Title
Outlet
Email
Reynolds Hutchins
Senior Reporter
The Daily Progress
rhutchins@dailypaper.com
Emily Hemphill
Business Reporter
The Daily Progress
ehemphill@dailypaper.com
Caite Hamilton
Editor
C-VILLE Weekly
editor@weekly.com
Nathan Alderman
Senior News Reporter
C-VILLE Weekly
news@weekly.com
Catie Ratliff
News Reporter
C-VILLE Weekly
reporter@weekly.com
Angilee Shah
Democracy Editor
Community News
a@communitynews.org
Akash Sinha
Reporter
Community News
b@communitynews.org
Erin O'Hare
Neighborhoods Reporter
Community News
eohare@communitynews.org
Hi,
[City] has a new name in the global life sciences C-suite.
[New CEO Name], a [City] biotech executive with more than 200 patents to their name, has been named Chief Executive Officer of [Company] — a global life sciences professional services firm headquartered in [HQ region] that helps pharmaceutical, biotech, and medical device companies bring products to market. [New CEO], who previously co-founded [Prior Company], steps up from President and Chief Innovation Officer, a role in which they have driven the company's growth and operations.
WHY YOUR READERS WILL CARE
[New CEO Name] is a [City] community member stepping into the CEO seat of a global life sciences firm — a local story with national reach.
200+ patents and a track record of building and commercializing therapies that reach patients — a compelling profile for local readers.
The announcement comes as [City]'s life sciences identity accelerates.
For [City], it's a local success story.
Outgoing CEO and founder [Founder Name], who built [Company] over 22 years, transitions to Executive Chairman, remaining actively involved in shaping the company's long-term direction.
This story is getting national life sciences industry coverage via BioBuzz today — I wanted to make sure you had the [City] angle.
For background materials or interview requests, please reach [Comms Contact]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Region B — Major Metro Area + Lab/Facility Location
Local angle anchored by the company's physical lab presence in this metro area.
Tier 1
Metro Business Journal
SubjectLeadership Transition at Life Sciences Firm with [Metro Suburb] Lab and [Metro]-Based Exec Team
📬 Recipients (12 contacts across 4 outlets)
Name
Title
Outlet
Email
John George
Senior Reporter
Metro Business Journal
jgeorge@bizjournals.com
Ryan Sharrow
Editor-in-Chief
Metro Business Journal
rsharrow@bizjournals.com
Michael Potter
Managing Editor
Metro Business Journal
mpotter@bizjournals.com
Alison McCook
Health & Science Reporter
Metro Daily Newspaper
amccook@inquirer.com
Kayla Yup
Health Reporter
Metro Daily Newspaper
kyup@inquirer.com
Sarah Gantz
Health Care Reporter
Metro Daily Newspaper
sgantz@inquirer.com
Aubrey Whelan
Public Health Reporter
Metro Daily Newspaper
awhelan@inquirer.com
Wendy Ruderman
Health Reporter
Metro Daily Newspaper
wruderman@inquirer.com
Sarah Huffman
Life Sciences & Tech Reporter
Technical.ly [Metro]
metro@technical.ly
Danya Henninger
Reporter/Editor
Technical.ly [Metro]
metro@technical.ly
James Walker
Business Reporter
Regional Business Report
jwalker@regionalbiz.com
Anna Reed
Industry Editor
Regional Business Report
areed@regionalbiz.com
Hi,
You've covered the [Metro] life sciences ecosystem as well as anyone — so I wanted to make sure this one crossed your desk with the local context you'd want.
[Company] — the global life sciences professional services firm with a device design and testing lab in [Metro Suburb] and senior executives based in the [Metro] region — has named [New CEO Name] as its new Chief Executive Officer. Alongside the CEO announcement, [Company] is appointing [New COO Name] as Chief Operating Officer.
WHY YOUR READERS WILL CARE
[Company] has a real [Metro] footprint — a device design and testing lab in [Metro Suburb] (expanded [year]) and senior executives based in the region.
The new COO, [New COO Name], co-founded [Acquired Company], a [Metro]-area engineering services firm that [Company] acquired in [year] — the region is where a key part of this leadership team was built.
Incoming CEO [New CEO Name] brings 200+ patents and a track record of building and commercializing therapies, taking over from a founder who is stepping up — not stepping away.
A leadership announcement with genuine local roots in [Metro]'s medtech/combination products ecosystem, not a distant HQ story with a thin regional hook.
Founder [Founder Name] transitions to Executive Chairman after 22 years leading the company.
This is not a distant corporate announcement with a thin [Metro] connection. [New COO] was the co-founder of [Acquired Company], a [Metro]-area engineering services firm that [Company] acquired in [year] — the acquisition brought [New COO] into the [Company] leadership team and anchored the firm's operations in the region.
BioBuzz is running an exclusive industry feature on this announcement today. I wanted to come to you with the [Metro] angle — which is the story your readers will connect with: a firm that operates here, whose COO built a company here, and is naming new leadership at a pivotal growth moment.
For background materials or interview requests, please contact [Comms Contact]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Tier 1 — National
National Trade Industry Press
SubjectCEO Transition at [Company] — Founder Steps to Chairman as New Leader Drives Next Phase of Growth
📬 Recipients (16 contacts across national life-sciences trade circle)
Name
Title
Outlet
Email
Ben Comer
Lead Editor
Life Science Leader
ben.comer@lifescienceleader.com
Meagan Parrish
Lead Editor
PharmaVoice (Industry Dive)
mparrish@industrydive.com
Michael Gibney
Senior Editor & Writer
PharmaVoice
mgibney@industrydive.com
Drew Armstrong
Executive Editor
Endpoints News
armstrong@endpts.com
John Carroll
Editor & Founder
Endpoints News
tips@endpts.com
Fraiser Kansteiner
Associate Editor
Fierce Pharma
fkansteiner@fiercepharma.com
Ben Fidler
Senior Editor
BioPharma Dive
bfidler@industrydive.com
Jacob Bell
Senior Reporter
BioPharma Dive
jbell@industrydive.com
Laura Chang
Editorial Director
STAT News
via statnews.com
John Sterling
Editor in Chief
GEN (Genetic Eng. & Biotech News)
jsterling@genengnews.com
Alex Philippidis
Senior Business Editor
GEN
aphilippidis@genengnews.com
Christopher Cole
Assoc. Editorial Director
Pharmaceutical Technology
ptpress@mmhgroup.com
Susan Haigney
Lead Editor
Pharmaceutical Technology
ptpress@mmhgroup.com
Dan Samorodnitsky
News Editor
BioSpace
dan.samorodnitsky@biospace.com
Heather McKenzie
Senior Editor
BioSpace
via biospace.com
Frank Vinluan
Senior Reporter, Biopharma
MedCity News
fvinluan@medcitynews.com
Hi,
A leadership transition that signals the maturation of one of the life sciences services sector's more quietly impressive growth stories.
[Company] — which provides end-to-end professional services across pharmaceutical, biotech, combination product, and medical device development, from pre-clinical through post-market — has promoted [New CEO Name] from President and Chief Innovation Officer to Chief Executive Officer. Founder [Founder Name], who built the company over 22 years, becomes Executive Chairman, remaining actively engaged in long-term strategic direction.
WHY YOUR READERS WILL CARE
A maturing life sciences services platform — covering pharma, biotech, and medtech from pre-clinical through post-market — making a planned, internal succession move that signals enterprise-scale positioning.
Incoming CEO [New CEO Name] has 200+ patents and co-founded [Prior Company]; the new COO co-founded [Acquired Company], an engineering services firm acquired by [Company] in [year] — two serial entrepreneurs now leading the next chapter.
[Company]'s service portfolio (combination products, biologics, advanced therapies, manufacturing services, quality & compliance) maps directly to the integrated outsourcing demands your readers are navigating.
For [Trade Publication] readers, the angles worth noting: [New CEO] brings 200+ patents and previously co-founded [Prior Company], where they helped take therapies from concept through commercialization. At the same time, [New COO] — who co-founded [Acquired Company], a [Metro]-area engineering services firm [Company] acquired in [year] — steps up to Chief Operating Officer. Two proven company-builders now leading the next chapter.
This transition is a signal that [Company] is positioning for the next phase of enterprise scale, not holding steady.
BioBuzz is covering the announcement today. For a deeper conversation about [Company]'s services strategy and where the company is headed, or for the full press release, please reach [Comms Contact]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Region C — HQ Region (Founder's Story)
Anchor angle in the headquarters region — the founder's 22-year story is the local story.
Tier 1
Regional Business Journal (HQ Region)
Subject[HQ Region] Founder Passes the Baton After 22 Years — [Company] CEO Transition
📬 Recipients (9 contacts across 6 outlets)
Name
Title
Outlet
Email
Zac Ezzone
Senior Reporter
Regional Business Journal
zezzone@bizjournals.com
Rebecca Troyer
Co-Reporter
Regional Business Journal
rtroyer@bizjournals.com
Dane Huffman
Managing Editor
Regional Business Journal
danehuffman@bizjournals.com
Sougata Mukherjee
Market President & Publisher
Regional Business Journal
via bizjournals.com
Catherine Clabby
Veteran Science Journalist
Regional Daily Newspaper
cclabby@regionaldaily.com
Rose Hoban
Founder & Editor
State Health News
rhoban@statehealthnews.org
Shannon Cuthrell
Contributing Writer
State Business Magazine
editor@statebiz.com
Editorial Desk
News Editor
Regional Tech/Biotech Newsletter
editor@regionaltech.com
Frank Vinluan
Senior Reporter, Biopharma
MedCity News
fvinluan@medcitynews.com
Hi [Reporter Names],
A [HQ Region] founder's succession story — 22 years in the making.
[Founder Name], who founded [Company] in [year] and moved its headquarters to [HQ Region] in [year], has spent over two decades building it into a leading global life sciences professional services firm. [Regional Business Journal] readers will know the company well: [Company] has appeared on [Publication]'s Fast 50 list of the fastest-growing companies in the [Region] multiple times, ranking [#X in year], [#Y in year], and [#Z in year] — and was a recipient of the [year] Life Sciences Award. This week, [Founder] transitions to Executive Chairman of the Board, passing the CEO role to [New CEO Name], the company's President and Chief Innovation Officer.
WHY YOUR READERS WILL CARE
[Founder Name] is the founder of [Company], based in [HQ Region] since [year] — this is the [Region]'s own founder-to-chairman succession story, 22 years in the making.
[Company] has been a consistent [Publication] Fast 50 honoree — and a Life Sciences Award recipient — making this a recognized [Region] growth company your readers already know.
The transition installs a successor with 200+ patents and a co-founder track record while keeping [Founder] actively engaged as Executive Chairman — continuity, not disruption.
New COO [New COO Name], previously co-founder of [Acquired Company] (acquired by [Company] in [year]), rounds out a strengthened leadership team built for the next growth phase.
It is a succession story built on trust and continuity, not disruption. [New CEO], who previously co-founded [Prior Company] and brings 200+ patents and 20+ years of life sciences leadership, has been the operational force behind [Company]'s growth. [Founder] remains actively engaged as Executive Chairman, with a stated focus on driving the company's strategy through [target year] and beyond.
Quote from founder (sample):
"[New CEO] is the ideal leader to shepherd [Company] into its next era of enterprise growth. As Executive Chairman, I will remain actively engaged in supporting [New CEO] and shaping our strategic direction for the years ahead."
— [Founder Name], Founder and incoming Executive Chairman, [Company]
BioBuzz is running an exclusive feature on this announcement today, covering the national industry story. I am coming to you with the [HQ Region] angle: a founder's legacy, a succession well-executed, and a company that grew up in this market continuing its trajectory.
For the full press release, additional background, or interview requests, please contact [Comms Contact]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Tier 1 — Regional Tech
Regional Tech/Biotech Newsletter & Local Axios
Subject[HQ City] Life Sciences Firm Names New CEO — Founder Stays as Chairman
📬 Recipients (5 contacts across 2 outlets)
Name
Title
Outlet
Email
Rick Smith
Editor / Founder
Regional Tech/Biotech Newsletter
editor@regionaltech.com
Jen Riehle McFarland
Reporter
Regional Tech/Biotech Newsletter
jmcfarland@regionaltech.com
Jodi Leese Glusco
Reporter
Regional Tech/Biotech Newsletter
jglusco@regionaltech.com
Zachery Eanes
Reporter
Local Axios
zachery.eanes@axios.com
Mary Helen Moore
Reporter
Local Axios
mhmoore@axios.com
Hi,
[Company], the [HQ City]-headquartered life sciences professional services firm, has promoted [New CEO Name] to Chief Executive Officer. Founder [Founder Name] — who built the company over 22 years — transitions to Executive Chairman, remaining actively involved in guiding long-term strategy.
WHY YOUR READERS WILL CARE
[Company] is a [HQ City]-headquartered life sciences firm with a strong local growth story.
Founder [Founder] transitions to Executive Chairman after 22 years; incoming CEO [New CEO] brings 200+ patents and co-founder experience.
Clean, planned succession — continuity of leadership in a fast-growing professional services firm serving pharma, biotech, and medtech clients.
[New CEO] brings 200+ patents and prior co-founder experience at [Prior Company], where they helped commercialize innovative therapies.
[Company] also named [New COO Name] — co-founder of [Acquired Company], acquired by [Company] in [year] — as Chief Operating Officer.
BioBuzz is running the full announcement today. For background materials or interview requests, please contact [Comms Contact]: [contact email].
Thank you for your time and consideration,
Sasha Whitaker
Amplification Partner Note
After earned media stories run, share clips with:
[State Biotech Center] — state biotech network media coverage pages and newsletters amplify regional life sciences news statewide. A brief email with a link to the BioBuzz piece and any regional business journal or TV coverage is all that's needed.
Regional TV News (TV/Digital) — for a major regional company milestone, the evening business segment is a real possibility if a tech/business desk reporter surfaces it to the broader newsroom.
Regional Business Journal Publisher — typically hosts annual Life Sciences Awards. This relationship has long-term value beyond a single pitch. A follow-up note after coverage runs, expressing appreciation, is a worthwhile investment.